EcoDrugPlus

Dopamine Receptor D3

Ensembl ID : ENSVPAG00000011966
Gene Symbol: DRD3
1 Cross references
206 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSVPAG00000000765
Gene Symbol: ENPP2
1 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSVPAG00000008331
Gene Symbol: EGLN1
1 Cross references
229 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSVPAG00000006928
Gene Symbol: EDNRA
1 Cross references
265 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSVPAG00000007744
Gene Symbol: EDNRB
1 Cross references
264 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSVPAG00000001437
Gene Symbol: EZH2
1 Cross references
222 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSVPAG00000009522
Gene Symbol: ERBB3
1 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSVPAG00000004261
Gene Symbol: ERBB4
1 Cross references
236 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSVPAG00000001185
Gene Symbol: ESR1
1 Cross references
211 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSVPAG00000004869
Gene Symbol: ESR2
1 Cross references
273 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSVPAG00000005190
Gene Symbol: ESRRG
1 Cross references
277 Possible Orthologues:

Exportin 1

Ensembl ID : ENSVPAG00000011446
Gene Symbol: XPO1
1 Cross references
304 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).